PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice

https://doi.org/10.1016/0091-3057(94)90235-6Get rights and content

Abstract

We investigated the effect of the σ selective PCP derivative PRE-084 on the impairment of learning induced in mice by the noncompetitive NMDA antagonist MK-801. Learning capacities were evaluated using the spontaneous alternation in a Y-maze test for spatial working memory, the step-down passive avoidance and the elevated plus-maze test for long-term memory. At doses about 1 mg/kg IP, PRE-084 significantly attenuated MK-801 (0.2 mg/kg IP) induced impairment of learning. The dose-response curve was bell-shaped which is typical for cognition enhancers. The effect of PRE-084 was antagonized by BMY-14802 (10 mg/kg IP) and suppressed by a chronic treatment with haloperidol (4 mg/kg/day SC for 7 days). Furthermore, PRE-084 did not affect scopolamine (1 mg/kg SC) induced amnesia but significantly attenuated mecamylamine (10 mg/kg IP) induced amnesia. These results show that σ sites mediate a modulation of the NMDA receptor complex-dependent learning processes and may similarly affect the cholinergic nicotinic memory processes. Moreover, the PCP derivative PRE-084, acting selectively at σ sites, reverses the amnesia induced by a drug acting at the PCP site.

References (42)

  • F.P. Monnet et al.

    N-methyl-D-aspartate-induced neuronal activation iσ selectively modulated by sigma receptors

    Eur. J. Pharmacol.

    (1990)
  • R. Quirion et al.

    A proposal for the classification of sigma binding sites

    Trends Pharmacol. Sci.

    (1992)
  • R. Quirion et al.

    Classification and nomenclature of phencyclidine and sigma receptor sites

    Trends Pharmacol. Sci.

    (1987)
  • N.G.H. Rückert et al.

    The σ ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophrenia

    Eur. J. Pharmacol.

    (1993)
  • J. Vignon et al.

    [3H]N-[1-(2-Benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): A new phencyclidine analog selective for the dopamine uptake complex

    Eur. J. Pharmacol.

    (1988)
  • J. Vignon et al.

    [3H]Thienyl-phencyclidine ([3H]TCP) binds to two different sites in rat brain. Localization by autoradiographic and biochemical techniques

    Brain Res.

    (1986)
  • A. Anis et al.

    The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-D-aspartate

    J. Pharmacol. Exp. Ther.

    (1983)
  • J. Ishikawa et al.

    Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment

    Brain Res.

    (1990)
  • J. Itoh et al.

    Utility of an elevated plus-maze for the evaluation of memory in mice: effect of nootropics, scopolamine and electroconvulsive shock

    Psychopharmacology

    (1990)
  • J. Itoh et al.

    Dynorphin A-(1–13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice

    Eur. J. Pharmacol.

    (1993)
  • Y. Itzhak et al.

    Differential regulation of σ and PCP receptors after chronic administration of haloperidol and phencyclidine in mice

    FASEB J.

    (1989)
  • Cited by (115)

    • Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo

      2022, Epilepsy and Behavior
      Citation Excerpt :

      Two behavioral tests were systematically used in parallel which address complementary memory processes. Spontaneous alternation performance in the Y-maze is an index of spatial working memory [34,37,38], while the step-through latency measured in the passive avoidance test is a non-spatial long-term memory parameter [34,37,39]. Drugs were tested in the 0.1–3 mg/kg dose range and we observed that Fenfluramine racemate and (+)-Fenfluramine significantly attenuated dizocilpine-induced learning deficits at the doses of 0.3 and 1 mg/kg (Fig. 1a–d). (

    • Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ<inf>1</inf>) receptor ligands with potent anti-amnesic effect

      2022, European Journal of Medicinal Chemistry
      Citation Excerpt :

      In general, σ1 receptor ligands referred to as agonists are devoid of cytotoxic activity in cancer cells, and neither of the two compounds tested were cytotoxic, indicating that they function as σ1 receptor agonists. Accordingly, we expected that our σ1 receptor agonists should produce anti-amnesic effects when evaluated by using two complementary behavioral tests, namely spontaneous alternation in the Y-maze (measuring spatial working memory) and a step-through-type passive avoidance response (measuring non-spatial long-term memory) [43–45]. Learning deficits were induced in mice (12 per group) by administering the noncompetitive NMDA receptor antagonist dizocilpine ((+)-MK-801 maleate) at a dose of 0.15 mg/kg intraperitoneally (ip) 20 min before the Y-maze test session or the acquisition session in the passive avoidance test [43,45].

    View all citing articles on Scopus
    View full text